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ABSTRACT: Isocyanide-based multicomponent reactions (IMCR) are by far the most versatile reactions that can construct
relatively complex molecules by one-pot synthesis. More importantly, the development of post IMCR modiﬁcations signiﬁcantly
improves the scaﬀold’s diversity. Here, we describe the use of N-Boc protected hydrazine together with α-amino acid derived
isocyanides in the Ugi tetrazole reaction and its post cyclization under both acidic and basic conditions. The cyclization in acidic
conditions was conducted in a one pot fashion, which give 7-aminotetrazolopyrazinone (6) and tetrazolotriazepinone (7) cyclic
products. The post cyclization under basic condition could selectively aﬀord Boc-protected 7-aminotetrazolopyrazinone (8)
products in yield of 38−87%.
KEYWORDS: isocyanide-based multicomponent reactions, hydrazine, post cyclization, tetrazole, one-pot synthesis, scaﬀolds diversity,
European Lead Factory
■ INTRODUCTION
Small molecules have always been of great interest in medicinal
chemistry and chemical genetics. They can provide oral leads
for drug discovery while maintaining favorable cost-of-goods or
can function as probes to illuminate the mechanism of the
biological processes in the living systems.1−4 Such small
molecule modulators are most commonly identiﬁed by high
throughput screening of large compound collections. The
European Lead Factory (ELF) supported by the Innovative
Medicines Initiative (IMI) is aiming to bring together 500 000
high-quality compounds library from both academia and
industry as the starting point for innovative drug discovery.5
A general consensus has emerged that library diversity, instead
of library size, is a crucial consideration. Multicomponent
reaction (MCR) chemistry is playing an important part in
generating highly diverse compound libraries as it is capable of
assembling novel molecular scaﬀolds and generating complex
functionalization motifs in just a few steps on a short time
scale.6−8 Furthermore, the exploitation of MCR-product
postcyclization has also become a very popular strategy to
generate complex skeletons.9−13
Ugi/de-Boc/cyclize (UDC) chemistry has been successfully
used in Hulme group.14 Recently, the application of the mono-
Boc protected hydrazine in the Ugi-tetrazole synthesis has been
ﬁrst explored in our lab.15 Herein, we show how α-amino acid
derived isocyanides together with hydrazine can be used to
obtain bicyclic scaﬀolds. We envisioned that both 6-membered
(6) and 7-membered (7) products could be formed under the
acidic conditions. Optimization of the protocol, with a
particular emphasis to selective obtainment of 6-membered
rings, as well as an application of the resulting compounds for
further diversiﬁcation, are described.
■ RESULTS AND DISCUSSION
The reaction of Boc-hydrazine 1 with acetone 2a, isocyanide
3a, and trimethylsilyl azide 4 was performed in methanol at
ambient temperature for 18 h which aﬀorded a moderate yield
of 5a (45%) (Scheme 1). It is well-known that Lewis acids
could help the activation of the Schiﬀ base and its formation
which can be the rate-limiting step in the Ugi-4CR.16 Hence,
we initiated our work by screening various Lewis acids such as
CF3SO3Li , CF3SO3Ag , CF3SO3K, (CF3SO3)2Mg,
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(CF3SO3)2Zn, ZnCl2, SnCl2, (CF3SO3)3In, and (CF3SO3)3Al as
the catalyst in the Ugi-4CR reaction (Table 1).
We found that divalent Lewis acid catalysts aﬀorded high
yields, (CF3SO3)2Mg was found to be the best catalysts
aﬀording 75% yield of 5a. ZnCl2 gave a similar good yield of
72%. In addition, (CF3SO3)2Zn and SnCl2 resulted in slightly
lower yields (62% and 60%). In contrast, poorer yields were
observed in the reactions catalyzed by other commonly used
Lewis acids. Hence, (CF3SO3)2Mg was the Lewis acid catalyst
of choice for the subsequent explorations.
With the optimal catalyst for Ugi-4CR in hand, the
conditions for postcyclization were further optimized. At ﬁrst,
we tried to cyclize the Ugi-adduct under acidic conditions in
one pot (Scheme 2). We speculated that it is possible to form
both 6-membered (6) and 7-membered (7) cyclized products
as the Boc-protecting group will be removed in acidic
condition. Although the 7-membered product suﬀered from
more strain during the ring formation than the 6-membered
product, the exposed primary amine would be also highly
interesting for further transformations.
We commenced our one pot postcyclization under acidic
conditions using Ugi-adduct 5a. Four diﬀerent acids: triﬂuoro-
acetic acid, acetyl chloride, 6 M aqueous hydrochloric acid, and
2 M methanolic hydrochloric acid were screened (Table 2).
Results showed that two equivalents of triﬂuoroacetic acid
aﬀorded poor yields of 6a (10%) and traces of 7a. When 6 M
aqueous hydrochloric acid solutions was used as the solvent, a
33% yield of the 6-membered product (6a) was aﬀorded.
Interestingly, two equivalent of acetyl chloride in methanol as
solvent gave 36% yield of the 6-membered product (6a), as well
as little amount of 7-membered product (7a, 5% yield).
Surprisingly, when we used 2 M methanolic hydrochloric acid
as solvent, the yield of 6-membered (6a) product signiﬁcantly
increased to 64% and minor 7-membered (7a) product (6%
yield) was formed. Hence, 2 M methanolic hydrochloric acid
was chosen as the acid for postcyclization. Furthermore, we
explored the possibility to accomplish the overall 2-step
sequence in a one-pot fashion. The unpuriﬁed Ugi-adduct
obtained was directly treated with 2 M methanolic hydrochloric
acid. We were pleased to observe that 43% of yield 6-
membered product 6a and 6% yield of 7-membered product 7a
could be obtained in the one-pot procedure. After these
interesting results, the generality of this one-pot procedure was
then explored by varying the isocyanide and oxo-components
(Table 3).
Various derivatives of methyl glycine isocyanides along with
ketones and aldehydes were synthesized. When we used methyl
glycine isocyanides with acetone, 6-memberd ring 6b was
obtained in 33% yield. Surprisingly, with cyclohexanone we
observed only a minor amount of 6-membered ring 6c (7%
yield) along with spiro-7-membered ring 7c (34% yield). A
similar trend was observed with isovaleraldehyde, that gave 7-
membered ring 7d in 29% yield accompanied by 6d in only
trace amount. With hydrocinnamaldehyde (entry 5), we
obtained 6e in 27% yield along with 10% yield of 7-memberd
ring (7e). Similar results were obtained with isobutyraldehyde
(entry 6), in this case we obtained 24% yield of 6f and 10%
yield of 7f. In addition, the isocyanide derived from methyl
phenylalaninate was used in combination with various oxo
components. With cyclopropanecarboxaldehyde (entry 7) and
acetone (entry 8) we obtained only 6-membered ring 6g and
6h in 23% and 30% yield, respectively. Cyclopentanone (entry
10), hydrocinnamaldehyde (entry 11) and isobutyraldehyde
(entry 12) gave only 6-memberd ring 6j (34% yield), 6k (15%
yield) and 6l (35% yield). In case of 6k and 6l, we observed the
diastereomeric mixtures in 25:1 and 1:1 ratio, respectively.
Cyclohexanone gave 6i (16% yield) and 7i (26% yield).
Interestingly, in the ﬁnal 7-membered product 7i we observed a
mixture of two ring-ﬂip conformers in 1:1 ratio in the NMR
spectra. A similar phenomenon is often observed in the related
7-membered benzodiazepines based on ring ﬂipping and axial
Scheme 1. Synthesis of Ugi-Adduct (5a)
Table 1. Screening of the Lewis Acid Catalysts for Ugi-
Tetrazole Adduct
entry catalyst conc. (equiv) yield (%)a
1 - - 45
2 ZnCl2 0.1 72
3 SnCl2 0.1 60
4 (CF3SO3)2Zn 0.1 62
5 CF3SO3Ag 0.1 43
6 CF3SO3K 0.1 47
7 (CF3SO3)2Mg 0.1 75
8 CF3SO3Li 0.1 53
9 (CF3SO3)3In 0.1 38
10 (CF3SO3)3Al 0.1 47
aIsolated yield.
Scheme 2. One-Pot Cyclization of Ugi-Adduct under Acidic Condition
Table 2. Screening of Acidic Conditions for Post-cyclization
yield (%)a
entry acid, solvent amount, time 6a 7a
1 TFA, MeOH 2 equiv., 18 h 10 traces
2 6 M aq. HCl 5 mL, 18 h 33 traces
3 acetyl chloride, MeOH 2 equiv., 18 h 36 5
4 2 M HCl in MeOH 5 mL, 4 h 64 6
aIsolated yield.
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and equatorial orientation of bulky substituents. Furthermore,
we tested the isocyanide derived from valine methyl ester with
various oxo-components like acetone and cyclohexanone.
Surprisingly, we were able to isolate only the 6-membered
ring 6m in 38% yield with acetone and exclusively the 7-
membered ring 7n in 40% yield with cyclohexanone. With
cyclopentanone (entry 15) we obtained 6-membered and 7-
membered ring 6o and 7o in 38% and 6% yield, respectively.
Although the overall yield of the one-pot reaction under acidic
condition is relatively low, we were surprised to ﬁnd that both
6-membered and 7-membered products were obtained. As we
can see from cyclization products 6e and 7e, 6f and 7f, and 6o
and 7o, 6-membered product was formed as the major product
and the 7-membered product was formed in less than 10%
yield. Notably, when cyclohexanone was used as the oxo-
component, the 7-membered ring was observed as the major
product (7c, 7i, and 7n). In general the yields and selectivity of
the reaction under acidic conditions was unsatisfactory.
Therefore, we tried to cyclize the Ugi-adduct under basic
conditions (Scheme 3, Table 4).
As the Boc-protecting group is generally stable under basic
conditions, only the 6-membered products with the Boc-group
on are expected to be formed. Initially, two bases (DIPEA and
NaOCH3) which are often used in cyclization chemistry were
evaluated. It was found that when they were used in catalytic
amounts, very poor yield was observed in both cases after 1h. In
addition, prolonging the reaction time from 1 to 12 h had little
eﬀect either. As NaOCH3 has given higher yield than DIPEA,
we further increased the amount of NaOCH3 to one equivalent,
which signiﬁcantly improved the reaction yield to 86%.
However, increasing the base amount to two equivalents failed
to further improve the reaction yield.
The results of the cyclization under basic condition are
summarized in Table 5. We tested diﬀerent methyl glycine
isocyanide derivatives obtained from various amino acids in
Ugi-tetrazole reaction with the various oxo-components. To
avoid the formations of diastereomeric mixture after the post
modiﬁcation on Ugi-adducts, we selected symmetric ketones as
oxo-components. Interestingly, with magnesium triﬂate as
Lewis acid catalyst in the Ugi-tetrazole reaction, good to
excellent yields of adducts (5a−5l, 56−90%) was obtained.
These pure isolated Ugi-tetrazole adducts were subjected to
cyclization with sodium methoxide (1 equiv) in methanol (0.5
M) at room temperature. All Ugi-tetrazole adducts (5a−5l)
gave 6-membered cyclized product (8a−8l) in moderate to
excellent yields (38−87%). Furthermore, we wanted to develop
this reaction sequence in one pot. To test this strategy, we
selected the methyl leucine isocyanide with acetone as an oxo-
component, mono-Boc hydrazine and TMSN3. We observed
the Ugi tetrazole adduct formation was good by SFC-MS and
TLC analysis. After the addition of sodium methoxide in the
reaction mixture for basic cyclization, we observed multiple
product formation. The major side product was the hydrolyzed
methyl ester of the Ugi-tetrazole adducts to the corresponding
acids; however, 8a was isolated only in 41% yield.
As we observed the one pot postcyclization under acidic
condition using Ugi-adduct 5 was poor yielding to compounds
Table 3. Typical Structures and Yields of Post-Cyclization
Product under Acid Condition
aOne-pot isolated yields. bdr ratio = 25:1. cdr ratio = 1:1.
Scheme 3. Cyclization under Basic Conditions
Table 4. Screening of Basic Conditions for Post-cyclization
entry catalyst conc. (equiv) time (h) yield (%)a
1 DIPEA 0.1 1 20
2 DIPEA 0.1 12 25
3 NaOCH3 0.1 1 33
4 NaOCH3 0.1 12 40
5 NaOCH3 1 1 86
6 NaOCH3 2 1 80
aIsolated yield.
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6. We further deprotected the compounds 8 under acidic
condition using 2 M methanolic hydrochloric acid at room
temperature for 18h (Table 6). We obtained exo-NHBoc
deprotected compounds as hydrochloric salts (9) in excellent
yields after evaporation of solvents.
To further support structural proof, we were also able to
grow crystals of some Ugi-adducts, 6-membered products and
7-membered products (Figure 1).
Lastly, the diversity application of the free exo-NH2 group in
compounds 6a for biological studies was accomplished by
synthesizing some derivatives through acylation, sulfonylation
and thiourea formation (Scheme 4). Compounds 6a reacted
with 1.2 equiv of acryloyl chloride to give compound 10 in 78%
yields. Upon treatment with 4-chlorobenzoyl chloride in DCE
under reﬂux, compound 11 (75% yield) was aﬀorded. The
reaction of 6a with 4-methylbenzenesulfonyl chloride led to 12
in 66% yield. In addition, 6a was also subjected to phenyl
thioisocyanate with pyridine in DCE to give 13 in 56% yield.
■ CONCLUSIONS
In summary, we described here the application of mono-Boc-
protected hydrazine in the Ugi tetrazole synthesis and its
postcyclization. Both 7-aminotetrazolopyrazinone (6) and
tetrazolotriazepinone (7) products were aﬀorded in one-pot
under acidic conditions. Under basic condition, Boc-protected
7-aminotetrazolopyrazinone (8) products were obtained in
good to excellent yield. The exposed free primary amine could
be further used as the building block to synthesize more
complex compounds.
Table 5. Typical Structures and Yields of Post-cyclization
Product under Basic Condition
aIsolated yields. bN-Boc rotamers.
Table 6. Deprotection of Compound 8
Figure 1. Crystal structures of 5a, 5d, 7e, 6h and 6j.
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